Java has endured radical transformations in the technology landscape and many threats to its prominence. What makes this technology so great, and what does the future hold for Java?

There is a specific category of startup risk that rarely gets discussed: the cost of outgrowing your own architecture before the product thesis is proven. naoo AG just addressed it head-on - replacing ...

The current OpenJDK 26 is strategically important and not only brings exciting innovations but also eliminates legacy issues like the outdated Applet API.

TEMPO.CO, Jakarta - The Meteorology, Climatology, and Geophysics Agency ( BMKG) warns that Jakarta and its satellite cities remain under threat from potential rain and strong winds through today, ...

Overview: Learning one programming language and core concepts builds the base for solving coding interview problems effectively.Strong knowledge of data structu ...

Using the right study materials can help strengthen the skills required to crack technical interviews in 2026. They aid in strengthening problem-solving skills, ...

The Eclipse Foundation has released the final version of GlassFish 8, an update of its enterprise Java application server. The new release serves as a compatible implementation of the Jakarta EE 11 ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andres Almiray, a serial open-source ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

We introduce VeriStruct, a novel framework that extends AI-assisted automated verification from single functions to more complex data structure modules in Verus. VeriStruct employs a planner module to ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...